Sex-biased Gene Expression and Gene-regulatory Networks of Sex-biased Adverse Event Drug Targets and Drug Metabolism Genes

Overview

Journal BMC Pharmacol Toxicol

Publisher Biomed Central

Specialty Pharmacology

Date 2024 Jan 3

PMID 38167211

Authors

Jennifer L Fisher

Amanda D Clark

Emma F Jones

Brittany N Lasseigne

Affiliations

Soon will be listed here.

Abstract

Background: Previous pharmacovigilance studies and a retroactive review of cancer clinical trial studies identified that women were more likely to experience drug adverse events (i.e., any unintended effects of medication), and men were more likely to experience adverse events that resulted in hospitalization or death. These sex-biased adverse events (SBAEs) are due to many factors not entirely understood, including differences in body mass, hormones, pharmacokinetics, and liver drug metabolism enzymes and transporters.

Methods: We first identified drugs associated with SBAEs from the FDA Adverse Event Reporting System (FAERS) database. Next, we evaluated sex-specific gene expression of the known drug targets and metabolism enzymes for those SBAE-associated drugs. We also constructed sex-specific tissue gene-regulatory networks to determine if these known drug targets and metabolism enzymes from the SBAE-associated drugs had sex-specific gene-regulatory network properties and predicted regulatory relationships.

Results: We identified liver-specific gene-regulatory differences for drug metabolism genes between males and females, which could explain observed sex differences in pharmacokinetics and pharmacodynamics. In addition, we found that ~ 85% of SBAE-associated drug targets had sex-biased gene expression or were core genes of sex- and tissue-specific network communities, significantly higher than randomly selected drug targets. Lastly, we provide the sex-biased drug-adverse event pairs, drug targets, and drug metabolism enzymes as a resource for the research community.

Conclusions: Overall, we provide evidence that many SBAEs are associated with drug targets and drug metabolism genes that are differentially expressed and regulated between males and females. These SBAE-associated drug metabolism enzymes and drug targets may be useful for future studies seeking to explain or predict SBAEs.

References

Kolberg L, Raudvere U, Kuzmin I, Vilo J, Peterson H . gprofiler2 -- an R package for gene list functional enrichment analysis and namespace conversion toolset g:Profiler. F1000Res. 2021; 9. PMC: 7859841. DOI: 10.12688/f1000research.24956.2. View

Ben Guebila M, Wang T, Lopes-Ramos C, Fanfani V, Weighill D, Burkholz R . The Network Zoo: a multilingual package for the inference and analysis of gene regulatory networks. Genome Biol. 2023; 24(1):45. PMC: 9999668. DOI: 10.1186/s13059-023-02877-1. View

Glass K, Huttenhower C, Quackenbush J, Yuan G . Passing messages between biological networks to refine predicted interactions. PLoS One. 2013; 8(5):e64832. PMC: 3669401. DOI: 10.1371/journal.pone.0064832. View

Chandak P, Tatonetti N . Using Machine Learning to Identify Adverse Drug Effects Posing Increased Risk to Women. Patterns (N Y). 2020; 1(7). PMC: 7654817. DOI: 10.1016/j.patter.2020.100108. View

Brambilla D, Matsumoto A, Araujo A, McKinlay J . The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men. J Clin Endocrinol Metab. 2008; 94(3):907-13. PMC: 2681273. DOI: 10.1210/jc.2008-1902. View

Shehab N, Lovegrove M, Geller A, Rose K, Weidle N, Budnitz D . US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014. JAMA. 2016; 316(20):2115-2125. PMC: 6490178. DOI: 10.1001/jama.2016.16201. View

Kvien T, Uhlig T, Odegard S, Heiberg M . Epidemiological aspects of rheumatoid arthritis: the sex ratio. Ann N Y Acad Sci. 2006; 1069:212-22. DOI: 10.1196/annals.1351.019. View

Longo S, Guo M, Ji A, Khavari P . Integrating single-cell and spatial transcriptomics to elucidate intercellular tissue dynamics. Nat Rev Genet. 2021; 22(10):627-644. PMC: 9888017. DOI: 10.1038/s41576-021-00370-8. View

Dotson A, Wang J, Chen Y, Manning D, Nguyen H, Saugstad J . Sex differences and the role of PPAR alpha in experimental stroke. Metab Brain Dis. 2015; 31(3):539-47. PMC: 4864150. DOI: 10.1007/s11011-015-9766-x. View

10.

Murtaza G, Khan A, Rashid R, Muneer S, Hasan S, Chen J . FOXO Transcriptional Factors and Long-Term Living. Oxid Med Cell Longev. 2017; 2017:3494289. PMC: 5574317. DOI: 10.1155/2017/3494289. View

11.

Carey J, Nader N, Chai P, Carreiro S, Griswold M, Boyle K . Drugs and Medical Devices: Adverse Events and the Impact on Women's Health. Clin Ther. 2017; 39(1):10-22. PMC: 5779632. DOI: 10.1016/j.clinthera.2016.12.009. View

12.

Kuijjer M, Tung M, Yuan G, Quackenbush J, Glass K . Estimating Sample-Specific Regulatory Networks. iScience. 2019; 14:226-240. PMC: 6463816. DOI: 10.1016/j.isci.2019.03.021. View

13.

Thong B, Tan T . Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol. 2011; 71(5):684-700. PMC: 3093074. DOI: 10.1111/j.1365-2125.2010.03774.x. View

14.

Yoon S, Jeong S, Jung E, Kim K, Jeon I, Lee Y . Effect of CYP3A4 metabolism on sex differences in the pharmacokinetics and pharmacodynamics of zolpidem. Sci Rep. 2021; 11(1):19150. PMC: 8476623. DOI: 10.1038/s41598-021-98689-z. View

15.

Davidson M, Ballinger K, Khetani S . Long-term exposure to abnormal glucose levels alters drug metabolism pathways and insulin sensitivity in primary human hepatocytes. Sci Rep. 2016; 6:28178. PMC: 4911593. DOI: 10.1038/srep28178. View

16.

Diker-Cohen T, Amitai O, Shochat T, Shimon I, Tsvetov G . Denosumab-associated hypocalcemia: Does gender play a role?. Maturitas. 2020; 142:17-23. DOI: 10.1016/j.maturitas.2020.07.003. View

17.

Moyer A, Matey E, Miller V . Individualized medicine: Sex, hormones, genetics, and adverse drug reactions. Pharmacol Res Perspect. 2019; 7(6):e00541. PMC: 6897337. DOI: 10.1002/prp2.541. View

18.

Zanger U, Schwab M . Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013; 138(1):103-41. DOI: 10.1016/j.pharmthera.2012.12.007. View

19.

Wilks C, Zheng S, Chen F, Charles R, Solomon B, Ling J . recount3: summaries and queries for large-scale RNA-seq expression and splicing. Genome Biol. 2021; 22(1):323. PMC: 8628444. DOI: 10.1186/s13059-021-02533-6. View

20.

Frost H . Computation and application of tissue-specific gene set weights. Bioinformatics. 2018; 34(17):2957-2964. PMC: 6129311. DOI: 10.1093/bioinformatics/bty217. View